Overview
Dynulta Tablet contains Sucroferric Oxyhydroxide 2500 mg, a phosphate binder used to control serum phosphorus levels in adult patients with chronic kidney disease (CKD) who are on dialysis. By binding dietary phosphate in the gastrointestinal tract, it prevents its absorption into the bloodstream, helping to manage hyperphosphatemia and reduce related complications.





